Aligos Therapeutics, Inc. - Common stock (ALGS)
6.2100
+0.1200 (1.97%)
NASDAQ· Last Trade: Sep 2nd, 6:10 PM EDT
Discover the top movers in Wednesday's pre-market session.chartmill.com
Via Chartmill · September 2, 2026
Gainers Can Fite Biopharma (AMEX:CANF) shares moved upwards by 20.4% to $3.96 during Wednesday's pre-market session. The company's market cap stands at $7.0 million. Aligos Therapeutics (NASDAQ:ALGS) shares
Via Benzinga · September 2, 2026
Keep an eye on the top gainers and losers in Monday's session.chartmill.com
Via Chartmill · August 10, 2026
The trading volume of these stocks is deviating from the norm in today's session.chartmill.com
Via Chartmill · July 8, 2026
Aligos Therapeutics (NASDAQ:ALGS) Surges After Hours on Q1 Earnings Beatchartmill.com
Via Chartmill · May 7, 2026
Aligos Therapeutics Inc (NASDAQ:ALGS) Reports Q4 Revenue Miss, Highlights 2026 Clinical Catalystschartmill.com
Via Chartmill · March 5, 2026
Monday's after hours session: top gainers and loserschartmill.com
Via Chartmill · July 6, 2026
Via Benzinga · August 27, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · March 10, 2025

The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via Chartmill · March 10, 2025

The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · March 10, 2025

Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQ:TSLA) and Palantir Technologies, Inc.
Via Benzinga · March 10, 2025

Via Benzinga · January 13, 2025
Triastek will develop oral RNA therapeutics with Germany’s BioNTech based on its 3D printing technology. Triastek will receive a $10 million upfront payment and up to $1.2 billion in milestones, plus royalties.
Via Talk Markets · July 27, 2024

ALGS stock results show that Aligos Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 7, 2024

Via Benzinga · March 15, 2024

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.
Via Benzinga · March 12, 2024
